ERBITUX sol perf 100 mg/20ml flac 20 ml
7680560720032
CH-56072
L01FE01
07.16.1.
Reimbursement limitations:
ERBITUX5
Le traitement nécessite une garantie de prise en charge des coûts par l'assureur-maladie après consultation …
1 / 3
google
Details
- Product number
- 5607202
- CPT
- -
- Packaging group
- 1 x 20
- Unit
- ml
- Composition
- cetuximabum 100 mg, natrii chloridum, glycinum, polysorbatum 80, acidum citricum monohydricum, natrii hydroxidi solutio 1 mol/L, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 58 mg.
Articles (1)
Erbitux 100 mg/20 ml, Infusionslösung
Infusionslösung
1 x 20
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
58.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 220.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2008
Authorization holder
Merck (Schweiz) AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 56072
- Drug name
- Erbitux, Infusionslösung
- Galenic form
- LSINF
- ATC Code
- L01FE01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 01/12/2003
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ERBITUX sol perf 100 mg/20ml flac 20 ml
- Description (DE)
- ERBITUX Inf Lös 100 mg/20ml Durchstf 20 ml
- Market launch
- 01/10/2007
- Narcotic (BTM)
- No